Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash dividend date
Announcement on behalf of the material subsidiary,
Bora Pharmaceutical Laboratories Inc., for the Board
resolution on cash dividend date
Date of events
2022/06/21
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or shareholders' meeting
or decision by the Company:2022/06/21
2.Type of ex-rights or ex-dividend (please enter: "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-dividend
3.Type and monetary amount of dividend distribution:
Common stock cash dividend, NTD 0.1416255 per share, total NTD 23,368,210.
4.Ex-rights (ex-dividend) trading date:2022/06/28
5.Last date before book closure:2022/06/29
6.Book closure starting date:2022/06/30
7.Book closure ending date:2022/07/04
8.Ex-rights (ex-dividend) record date:2022/07/06
9.Deadline for applying the conversion of the debt voucher:NA
10.The closure period for the conversion of the debt voucher will
start from the date:NA
11.The closure period for the conversion of the debt voucher
will end on the date:NA
12.Payment date of cash dividend distribution:2022/07/15
13.Any other matters that need to be specified:NA
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bora Pharmaceuticals Co. Ltd. published this content on 21 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2022 10:24:03 UTC.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash dividend date
BORA PHARMACEUTICALS CO., LTD. 
